Company Valuation: LifeMD, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 118.4 61.01 325 214.4 164.1 203.1 - -
Change - -48.47% 432.67% -34.03% -23.44% 23.75% - -
Enterprise Value (EV) 77.74 61.01 325 214.4 164.1 203.1 203.1 203.1
Change - -21.52% 432.67% -34.03% -23.44% 23.75% 0% 0%
P/E -1.69x -1.24x -11.8x -9.34x -19.5x -15.4x 56.5x 13.5x
PBR - - - - - - - -
PEG - 0x 0.2x 0.4x 0.3x -0.3x -0x 0x
Capitalization / Revenue 1.27x 0.51x 2.13x 1.01x 0.85x 0.91x 0.78x 0.67x
EV / Revenue 0x 0x 0x 0x 0x 0.91x 0.78x 0.67x
EV / EBITDA -0x -0x 0x 0x 0x 15.4x 6.59x 4.05x
EV / EBIT -0x -0x -0x -0x -0x -21.2x 26.7x 8.58x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -2.29 -1.57 -0.7 -0.53 -0.1753 -0.2729 0.0743 0.31
Distribution rate - - - - - - - -
Net sales 1 92.88 119 152.5 212.5 194.1 222 260.9 302.7
EBITDA 1 -38.28 -14.66 11.98 14.38 15.25 13.22 30.8 50.21
EBIT 1 -54.3 -43.45 -14.49 -16.14 -7.67 -9.572 7.616 23.67
Net income 1 -61.77 -48.64 -23.7 -21.99 -7.913 -13.11 3.574 15.8
Net Debt -40.66 - - - - - - -
Reference price 2 3.870 1.940 8.290 4.950 3.410 4.200 4.200 4.200
Nbr of stocks (in thousands) 30,593 31,450 39,203 43,312 48,136 48,363 - -
Announcement Date 3/7/22 3/22/23 3/11/24 3/10/25 3/9/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-15.14x - - - 200M
26.79x5.66x12.53x-.--% 27.84B
82.02x74.67x87.44x0.44% 13.62B
93.23x14.71x63.26x0.69% 5.43B
-47.53x12.8x-68.62x - 3.07B
-7.2x73x-7.39x - 2.11B
51.45x - - -.--% 1.83B
-130.53x - - - 1.22B
25.22x5.04x10.84x1.91% 740M
-104.67x - - 1.27% 715M
Average -2.64x 30.98x 16.34x 0.72% 5.68B
Weighted average by Cap. 36.70x 27.49x 31.52x 0.24%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. LFMD Stock
  4. Valuation LifeMD, Inc.